Visualize first — key quantitative readouts from the paper are plotted below (DNA binding, mammalian-cell reporter activation, yeast GAL4 activation, and subcellular localization counts). All numerical values are taken from the preprint (DOI:10.1101/2025.01.21.634164) and are cited below.
- Claim: Jellyfish NF-κB proteins specifically bind κB DNA sites — convincing within the assay context (strong, sequence-competition controls give confidence).
- Claim: These NF-κB proteins do not activate a κB-site reporter in HEK cells — valid for the heterologous HEK assay, but cannot be generalized to jellyfish biology (moderate, assay-limited).
- Claim: IκB-like proteins interact and regulate subcellular localization — supported by co-IP, localization shifts, and AlphaFold docking (moderate-to-strong within heterologous systems).
- Claim: NF-κB functions in early development in Clytia — plausible given mRNA patterns but currently inferential; requires in vivo perturbation for confirmation (weak-to-moderate).
Basal metazoan NF-κB proteins can retain conserved DNA-recognition geometry while evolving species-specific regulatory interfaces and co-factor dependencies that decouple DNA binding from transactivation in heterologous systems — implying that surveying only DNA-binding is insufficient to infer regulatory function across phyla ().
Add at least one native-organism perturbation (morpholino or CRISPR) or ChIP experiment; provide western/protein-level quantification across stages to validate mRNA inferences; attempt co-expression of candidate jellyfish co-factors in HEK or use jellyfish primary cells / explants to test activation directly.
Notes on evidence strength: conclusions about molecular interactions, DNA binding and localization are supported by direct biochemical and cell-based assays reported in the preprint; organismal/developmental claims are plausible but inferential and require perturbation experiments in the native animals for stronger support ().
Custom summaries of the latest cutting edge Science research. Every Friday. No Ads.